Influence of renal clearance on peripheral homovanillic acid measurements in healthy subjects and schizophrenic patients

1993 ◽  
Vol 11 (1) ◽  
pp. 33-40 ◽  
Author(s):  
Charles L. Whelton ◽  
Ram N. Gupta ◽  
John M. Cleghorn ◽  
Shannon R. Ballagh
1998 ◽  
Vol 13 (6) ◽  
pp. 303-309 ◽  
Author(s):  
I Berlin ◽  
L Givry-Steiner ◽  
Y Lecrubier ◽  
AJ Puech

SummaryAnhedonia may be considered as a transnosological feature of depression and schizophrenia. The aim of the present study was to assess hedonic responses to sucrose solutions and sweet taste perception threshold in patients with major depression and in schizophrenic patients in comparison with healthy subjects (matched for age and gender with depressive patients), and to compare these responses to evaluations by the Physical and Social Anhedonia scale of Chapman and the Pleasure Scale of Fawcett, generally used to quantify anhedonia. Hedonic responses to sucrose solutions were similar in patients with major depression (n = 20), schizophrenia (n = 20), and healthy controls (n = 20). Sweet taste perception threshold was significantly higher in depressive patients than in controls. Hedonic response to sucrose was inversely correlated with physical Anhedonia Scores and sweet taste perception threshold with Pleasure Scale scores. Measures of hedonia/anhedonia were not related with the intensity of depression or anxiety as measured by the Montgomery-Asberg Depression Rating Scale (MADRS) and Hamilton Anxiety Scale, respectively. In 11 depressed patients hospitalised for 17 to 33 days, neither hedonic ratings to sucrose solutions, sweet taste perception threshold, Physical, Social Anhedonia scores nor Pleasure Scale scores were modified in spite of substantial decrease in MADRS or Hamilton Anxiety scores. Hedonic responses to sucrose solutions and sweet taste perception threshold may be used as complementary evaluation to quantify anhedonia.


1992 ◽  
Vol 15 ◽  
pp. 259B
Author(s):  
E. Suzuki ◽  
S. Kanba ◽  
M. Nibuya ◽  
F. Shintani ◽  
N. Kinoshita ◽  
...  

1996 ◽  
Vol 11 (1) ◽  
pp. 16-20 ◽  
Author(s):  
G Oxenstierna ◽  
G Bergstrand ◽  
G Edman ◽  
L Flyckt ◽  
H Nybäck ◽  
...  

SummaryIn a previous cisternographic study of the cerebrospinal fluid (CSF) circulation in schizophrenic patients, indications for disturbed flow dynamics were found in 10 of 30 subjects. In order to replicate and investigate the clinical and pathophysiological significance of this finding, 39 schizophrenic patients and 42 healthy subjects were examined with an improved method for measurement of CSF circulation. 99mTc-DTPA was injected intrathecally and the gamma cisternograms were evaluated blindly. Correlations between cisternography findings and age, duration of disease, previous hospitalizations, positive or negative symptomatology, exposure to neuroleptics, psychiatric family history, CT findings and CSF levels of protein, tryptophan and monoamine metabolites, were calculated. Seven of the patients showed abnormalities in the cisternograms with a slow or obstructed flow of CSF over the convexities (P < 0.01) whereas none of the healthy volunteers showed abnormalities. There were no correlations between disturbed CSF circulation in the patients and the clinical and biochemical parameters, thus the significance of the deviations, similar to other biological aberrations found in schizophrenic patients, is not known. Recent developments in magnetic resonance imaging offer new possibilities to further examine CSF circulation abnormalities in schizophrenia.


2000 ◽  
Vol 41 (1) ◽  
pp. 131-132
Author(s):  
N. Mjellem ◽  
A. Lund ◽  
K. Hugdahl ◽  
B. Rund ◽  
N.I. Landrø ◽  
...  

1974 ◽  
Vol 35 (4) ◽  
pp. 287-294 ◽  
Author(s):  
Bengt Fyr� ◽  
Birgitta Wode-Helgodt ◽  
Stefan Borg ◽  
G�ran Sedvall

1983 ◽  
Vol 142 (3) ◽  
pp. 288-291 ◽  
Author(s):  
W. F. Gattaz ◽  
H. Cramer ◽  
H. Beckmann

SummaryIncreasing evidence suggests that the concentrations of cyclic guanosine 3′5′-monophosphate (cGMP) in the cerebrospinal fluid (CSF) may reflect central cholinergic activity. When the concentrations of this nucleotide in the CSF from 28 schizophrenic patients (13 without and 15 with neuroleptic treatment) and 16 psychiatrically healthy controls was determined the schizophrenics showed significantly lower CSF levels of cGMP as compared to controls.As dopamine and homovanillic acid concentrations were not altered in these CSF samples, this finding of reduced cGMP suggests a cholinergic-dopaminergic imbalance in schizophrenia, with a reduction of the former and consequently a relative dominance of the latter.


Sign in / Sign up

Export Citation Format

Share Document